Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2003

Oct 3, 2003

29777_dirs_2003-10-02_97c961ca-b693-4629-a528-a6223a66bbd1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2003-10-01

Reporting Person: NEMMERS JOSEPH M (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2003-10-01 Common shares without par value A 10000 $42.44 Acquired 49901 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2003-10-01 Option (right to buy) $42.44 A 20000 Acquired 2013-09-30 common shares (20000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 10274 Indirect
Common shares without par value 328 Indirect
Common shares without par value 328 Indirect
Common shares without par value 275 Indirect
Common shares without par value 269 Indirect

Footnotes

F1: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The award includes the right to have stock withheld for tax purposes.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of September 30, 2003.

F3: Reporting person disclaims beneficial ownership of all securities held by his sons.

F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 6,667, 6,666 and 6,667 beginning on 10/01/04, the first anniversary date of the grant.